Inventis to Distribute PATH Medical OAE and ABR Testing Devices in North America

Image
HHTM
October 19, 2021

PADUA, ITALY — Audiology equipment manufacturer, Inventis, announces the distribution of the PATH MEDICAL instruments in North America. Inventis is enlarging its product portfolio by entering the OAE and ABR diagnostic segment and “strengthening its position in the North American market.”

With its full range of audiometers, middle-ear analyzers, and fitting systems, marketed in more than 65 countries around the world, Inventis continues to grow and expand its offerings.

Founded in 2005 with headquarters in Padua, Italy, Inventis has always been extremely focused on exports, and in 2018 opened a subsidiary in the US to reinforce its presence in its most important market after the domestic one.

PATH MEDICAL is a Germany based company that has unique algorithms and technologies “considered to be the new frontier in Audiology practice”. The team of PATH MEDICAL has a tremendous footprint in the industry since 1998 as they are said to be responsible for developing some of the best known Newborn Hearing Screeners.

“We’re thrilled to unfold our presence in the North American market. By extending the range of our products we aim to unlock the full potential of innovation and digital transformation and place our clients on the best path for success in the audiology landscape. We aim to provide a full range of solutions for hearing assessment from 0 to 99 years.”

–Riccardo Rizzoli, Inventis NA CEO

 

ABOUT INVENTIS

Inventis is an audiology leader providing instrumentation and software solutions to hearing and balance care professionals around the world. From our team of engineers to our worldwide distributors, Inventis is committed to being a reliable and innovative manufacturer of medical devices. Inventis develops and manufactures cutting-edge audiology equipment including, audiometers, middle ear analyzers and hearing aid fitting solutions. For more information, please visit www.inventis.it

 

Source: Inventis

Leave a Reply